Helios agrees to acquire majority stake in Moroccan MedTech group

29th July 2021

Helios has entered into an agreement to acquire a majority stake in the largest and most diversified group of MedTech companies in Morocco. The consolidated group operates in medical devices, in vitro diagnostic and pharmaceuticals, and comprises four companies: Techniques Science Santé (“T2S”), IM Alliance, Cyclopharma and Binarios.

Cliquez ici pour télécharger

Our Investments

Helios investit dans des sociétés de plates-formes diversifiées et leaders du marché opérant dans les secteurs économiques clés.

+